Mary H. Hanlon

Regulation of HDM2 activity by the ribosomal protein L11

Marion Lohrum, Robert L. Ludwig, Michael H.G. Kubbutat et al. · Cancer Cell · 2003 · 616 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Michael Maguire, Rosario Guinea, Philip Griffin et al. · Journal of Virology · 2002 · 158 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385

John F. Miller, C. Webster Andrews, Michael Brieger et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Characterization of C/EBPβ isoforms in normal versus neoplastic mammary epithelial cells

Erin M. Eaton, Mary H. Hanlon, Linda M. Bundy et al. · Journal of Cellular Physiology · 2001 · 69 citations

Life Sciences, Cell Biology, Molecular Biology +13

ERK2- and p90Rsk2-dependent Pathways Regulate the CCAAT/Enhancer-binding Protein-β Interaction with Serum Response Factor

Mary H. Hanlon, Thomas W. Sturgill, Linda Sealy · Journal of Biological Chemistry · 2001 · 62 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14